Pfizer and Hisun ink a joint venture as Chinese market the next big target
China market is the next big target for Pfizer as the pharmaceutical giant inks a new deal of a joint venture with a Chinese partner, Zhejiang..
Archive for reneetan
Vivo Ventures another company which seeks to ride the dragon
It is a common fact among pharmaceutical industry that China is a rapidly maturing market. Vivo Ventures is another company which endeavours..
Merck gains traction in Brazil with joint venture
Brazilian pharma market is the next target for U.S. pharmaceutical giant Merck as a new partnership is being proposed with Supera Farma Laboratorios,..
Lonza teams with South Africa on antiretroviral API plant
An alliance with the South African government has been established by Swiss drug manufacturer Lonza on a new, $210 million plant to produce antiretroviral..
Eisai shifts focus to East Asia
The announcement by Eisai to pull back in the US and refocus on East Asia came as no surprise as markets such as China continues to grow while..
Japanese drugmakers a growing presence in M&A
Japanese drugmakers have resorted to M&A to cushion the blow in earning due to patent losses and lower drug prices. Astellas Pharmas in..
Sanofi and Novartis pull out of bidding war for Illumina
The mounting speculation that Sanofi or Novartis might join Roche in a bidding war for Illumina has disappeared following indication of..
Micromet $1.2 billion anti-cancer pipeline purchased by Amgen
Global biotech firm, Amgen has announced its acquisition of German/U.S. cancer drug developer, Micromet for $1.2 billion. The buyout means that..
Vaccine production boosted by collaboration between GSK and Alnylam
Good news for governments around the world who wish to establish national disease protection programs! GlaxoSmithKline has allied with Alnylam..
Pfizer’s aggressive Lipitor strategy succeed in numbers
The aggresive sales strategies on Lipitor by Pfizer has started showing positive results as initial drop of sales has halted according to..
